ArticleCancer medicine2026

Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Survival Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy.

Pablo Llerena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.